Latest update
$76.70
Updated: Apr 28, 2026, 1:21 PM UTC
Browsing public data
Loading fundamentals
Pulling sales, cash, and growth data for ABBN.SW.
This is a tactical timing call on a momentum stock with genuine structural tailwinds but stretched valuation. The markup phase is confirmed on weekly timeframe, yet daily exhaustion near highs and pathetic FCF conversion relative to market cap demand humility. I am calling BUY only for actors with discipline to add on pullback to daily 21 EMA rather than chase; fundamental case demands 2-3 year holding period for FCF inflection to validate multiple. Not a broad business verdict—business is fine, price is demanding.
Short-term thesis
There may be a trade here, but it is not a clean long-term hold.
Long-term exposure
Avoid
The business or valuation backdrop is not ready for long-term conviction.
Entry window
Add now
The setup still offers a usable entry in this window.
Risk check
Fragile
The downside can widen quickly if this setup goes wrong.
Alignment
Mixed
Neither horizon fully wins, so size and patience matter.
What supports it
What limits it
Long-term thesis
Global electrification, automation, and energy efficiency mandates are structural demand drivers across utilities, manufacturing, and data centers; ABB operates at the chokepoint of industrial digitization and grid modernization as a top-3 global player in electrification and process automation.
Demand Gap
Grid infrastructure investment needs estimated at $21T globally through 2030 to meet electrification and renewable targets; current annual spend running at roughly half required pace, with medium-voltage equipment lead times already extending 6-12 months
Dependency Chain
Must be true
Thesis broken if
Jan 21, 1970
LatestUpdated Apr 28, 2026, 1:21 PM UTC
Price at review
$76.70
Price has extended 15.8% above weekly 21 EMA with strong multi-month momentum, but daily picture shows potential early-stage digestion after rejection near 52-week highs; volume declining on pullbacks suggests supply not yet flooding in. Near-term entry chasing here risks a sharper reversion to $72-73 daily 21 EMA zone.